Mixed migraine results for PFO closure study
Percutaneous closure of patent foramen ovale did not significantly lessen the frequency of migraines in patients with episodic migraines, according to a study published yesterday in the Journal of the American College of Cardiology.
Although the Premium trial missed its primary endpoint, the study met the secondary endpoint of reducing migraine days after PFO closure.
A sub-group analysis also found that patients with frequent aura experienced a significant reduction in migraine attacks with PFO closure. One of the trial’s investigators told Medscape that there is validity to right-to-left shunt closure, as long ...
Source: Mass Device - December 7, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Neurological Wall Street Beat stjudemedical Source Type: news
PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk? PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk?
New research suggests that reducing patent foramen ovale size could lessen stroke risk, while other work explores the role that PPIs might play in causing dementia.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news
Data Boosts Support for Abbott, Gore PFO Closure Tech
Devices designed to lower a patient's stroke risk by surgically closing a hole in the heart known as a patent foramen ovale, have historically had a tough time in clinical trials. Data from three separate studies published in the New England Journal of Medicine could go a long way toward boosting support two market-leading PFO closure devices, but figuring out who should have the procedure and who should not continues to be a gray area for clinicians and patients.
Long-term results from the RESPECT trial, which evaluated the Amplatzer device that Abbott acquired when it bought St. Jude Medical, along with new data from G...
Source: MDDI - September 15, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M Minneapolis R Medical Device Business Source Type: news
Landmark Study Published in the New England Journal of Medicine Shows Abbott's AMPLATZER ™ Device Significantly Reduces Risk of Recurrent Stroke for People Living with a Hole in their Heart
-One in four people live with a small opening between the upper left and right chambers of the heart, called a patent foramen ovale (PFO), that increases their risk for recurrent stroke (Source: Abbott.com)
Source: Abbott.com - September 14, 2017 Category: Pharmaceuticals Source Type: news
Device used to close small hole in heart may protect against recurrent stroke
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial led by UCLA researchers.“It is a major new treatment option for some people,” said Dr. Jeffrey Saver, director of theUCLA Comprehensive Stroke Center and lead author of the study. However, he added, “Using the device is going to have to be a considered clinical decision between the doctor and the patient about who’s the right person to get it.”Thefindings appear in the Sept. 14 New England Jo...
Source: UCLA Newsroom: Health Sciences - September 14, 2017 Category: Universities & Medical Training Source Type: news
PFO Closure Reduces Stroke Recurrence PFO Closure Reduces Stroke Recurrence
Three new studies provide evidence that closure of patent foramen ovale in select patients after stroke reduced the stroke recurrence rate compared with medical therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
ESOC 2017 Roundup: Gore touts lowered ischemic stroke, new brain infarcts in PFO Occluder test
W.L. Gore & Associates yesterday released results from the Reduce study of its Cardioform Septal Occluder devices used to close patent foramen ovale, touting a reduction in recurrent ischemic strokes and new brain infarcts.
The Gore Cardioform Septal Occluder is designed to be inserted via catheter and is currently cleared by the FDA for closure of atrial septal defects.
“It is of the utmost importance to us to be transparent and share clinical data as quickly as possible. We completed our two-year primary endpoint follow-up with patients in March and have worked diligently to release these important data to the ...
Source: Mass Device - May 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Catheters Clinical Trials Stryker W.L. Gore & Associates Source Type: news
Finally, Success Reducing Recurrent Stroke With PFO Closure Finally, Success Reducing Recurrent Stroke With PFO Closure
Two new clinical trials showing a reduction in recurrent strokes with the closure of a patent foramen ovale (PFO) look set to change clinical practice.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 17, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
PFO closure is more effective than medical management in preventing recurrent stroke, long-term study results show
Percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke, final results from the RESPECT trial found. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 1, 2016 Category: Science Source Type: news
Final results from the RESPECT study reported at TCT 2016
(Cardiovascular Research Foundation) Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 1, 2016 Category: Global & Universal Source Type: news
FDA Approves First PFO Occlusion Device to Prevent Recurrent Stroke (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH
The FDA on Friday approved a patent foramen ovale (PFO) occlusion device to help prevent recurrent stroke in patients with a PFO who ' ve had an … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 30, 2016 Category: Primary Care Source Type: news
HeartStitch(R) Presence in PFO Closure Hits New Milestone
FRANKFURT, GERMANY and MILAN, ITALY and ROME, ITALY and ALMATY, KAZAKHSTAN--(Healthcare Sales & Marketing Network) - HeartStitch® Inc, continues to increase its presence in Interventional Cardiology with continued successful cases worldwide. These rece... Devices, Interventional, Cardiology HeartStitch, NobleStitch, patent foramen ovale, PFO closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 6, 2016 Category: Pharmaceuticals Source Type: news
Jul 29 Cardiology News Jul 29 Cardiology News
Potential underuse of cardiac tests in heart failure, an antidote for prolonged sitting, and a new practice advisory from the AAN on patent foramen ovale (PFO) closure and stroke. < br / > < i > theheart.org on Medscape < /i > (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 29, 2016 Category: Consumer Health News Tags: Cardiology News Source Type: news
AAN recommends against routine closure of patent foramen ovale for secondary stroke prevention
An updated practice advisory from the American Academy of Neurology does not recommend the routine use of catheter-based closure of patent foramen ovale in patients with a history of cryptogenic... (Source: Family Practice News)
Source: Family Practice News - July 27, 2016 Category: Primary Care Source Type: news
AAN recommends against routine closure of patent foramen ovale for secondary stroke prevention
An updated practice advisory from the American Academy of Neurology does not recommend the routine use of catheter-based closure of patent foramen ovale in patients with a history of cryptogenic... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 27, 2016 Category: Neurology Source Type: news
